
The biotech industry rose to prominence during the pandemic as it was vital in bringing vaccines and therapies. Despite witnessing a slowdown, the biotech industry is well-positioned for long-term growth.
Amid this backdrop, it could be wise to buy fundamentally strong biotech stocks Corcept Therapeutics Incorporated (CORT), Ligand Pharmaceuticals Incorporated (LGND), and Acorda Therapeutics, Inc. (ACOR) to capitalize on the industry tailwinds.